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RAILTY in older adults has been characterized as a syndrome of weakness, declines in activity, weight loss, and vulnerability to adverse health outcomes (1) (2) (3) . Although recent studies have identified increased inflammatory mediators and decreased muscle-related hormones as important correlates of frailty and adverse health outcomes in older adults, etiological mechanisms for frailty have not been identified (4) (5) (6) (7) (8) (9) (10) (11) . Given the influence of frailty on the health and well-being of aging adults, and the inherent difficulty associated with performing biological studies in frail and vulnerable aging humans, the development of animal models for frailty represent an important next step toward the development of etiologic and intervention-focused studies on frailty (12) . To develop animal models for frailty, researchers have suggested that the models should display the common signs and symptoms of human frailty, including muscle weakness, decreased activity, weight loss, inflammation, and hormonal and muscle changes. In addition, these signs and symptoms should develop first later in the life span and not be attributable to specific disease states (12) .
The interleukin 10 homozygous deletion mouse (IL-10 tm/tm ) produces none of the antiinflammatory cytokine IL-10, which in turn leads to increased expression of nuclear factor-kappa B (NF-jB)-induced inflammatory mediators (13) (14) (15) . Although earlier studies demonstrated that these mice were vulnerable to inflammatory bowel diseases, growth retardation, anemia, and early mortality, subsequent studies of tm/tm mice maintained in barrier conditions revealed minimal evidence for these conditions and near normal survival rates (16) . Given this background and the knowledge that chronic activation of inflammatory mediators likely influence frailty in older adults, we hypothesized that IL-10 tm/tm mice would become weaker, thinner, and less active and that they would develop increased levels of IL-6 and altered skeletal muscle gene expression at older ages compared to age-and gender-matched C57BL/6J background control mice.
METHODS
Specific pathogen free (SPF) IL-10-deficient B6.129P2-Il10 tm1Cgn (IL-10 tm/tm ) mice fully backcrossed on C57BL/6J background and age-and gender-matched C57BL/6J background mice were used for this study (16) .
All mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and were maintained under barrier conditions to prevent pathogen contact (15) (16) (17) . Each mouse received an ear tag with a specific identification number to ensure correct longitudinal data collection. Genotype for each mouse was confirmed using a previously developed polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay http://jaxmice. jax.org/pub-cgi/protocols/protocols.sh?objtype¼protocol &protocol_id¼356.
Mice were housed in Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International-accredited facilities in compliance with the Guide for the Care and Use of Laboratory Animals, and all procedures were approved by the Institutional Animal Care and Use Committee. Mice were housed in 75-square-inch high temperature polycarbonate shoebox cages in ventilated racks (Allentown Inc., Allentown, NJ) containing autoclaved corncob bedding (Harlan Teklad, Indianapolis, IN), autoclaved mouse chow 2018SX (Harlan Teklad), and reverse-osmosis-filtered hyperchlorinated water dispensed through an in-cage automatic watering system (Edstrom Industries, Waterford, WI). Rooms were maintained at 728F 6 28F on a 14-hour light/10-hour dark cycle with automated monitoring by Siemens Building Technologies, Inc. (Zurich, Switzerland). Cages were sanitized every 2 weeks in laminar airflow change stations (The Baker Co., Sanford, ME) using MB-10 disinfectant (Quip Laboratories, Inc., Wilmington, DE).
Colonies were monitored for infection through one sentinel cage per rack (70 cages) exposed to soiled bedding from every cage and were tested on a rotating schedule so that each rack was tested every 4 months. The following pathogens were excluded: ecto-and endoparasites, mouse hepatitis virus, epidemic diarrhea of infant mice, Theiler's murine encephalomyelitis virus, mouse parvovirus I, mouse minute virus, mouse adenovirus type 2, ectromelia virus, lymphocytic choriomeningitis virus, Mycoplasma pulmonis, pneumonia virus of mice, reovirus, Sendai virus, and mouse cytomegalovirus. Additional PCR testing of fecal material was performed to rule out Helicobacter species in these mice.
For longitudinal measurement of weight, activity, and strength, 10 40-week-old female C57BL/6J control and 10 40-week-old female IL-10 tm/tm mice were kept at least 1 month in barrier conditions before data were collected to minimize shipping-related stimulation of inflammation. Phenotypic data were collected monthly through age 18 months. Weight was measured using a PB3002 Delta Range balance (Mettler Scales, Toledo, OH). Muscle strength was measured monthly with a Grip Strength Meter (Columbus Instruments, Columbus, OH) with a sensor range of 0-500 grams, and accuracy of 0.15% (18) . Each mouse was held by the tail and allowed to grasp the apparatus with front paws while steady pressure was applied to the tail, and the measurement was taken just before release (maximum tensile force). Five measurements were averaged. For monthly activity measurements, each mouse was placed alone into a separate cage beginning at age 14 months, and movements were recorded by an observer who was unaware of the genotype of the mouse. Traveling activity was measured by counting the number of times a mouse crossed completely over the midline of the cage during a 5-minute period. Standing activity (rearing behavior) was measured by counting each time the mouse balanced itself on its hind paws while extending its body vertically onto the wall of the cage or without cage support during a 5-minute period. A linear mixed-effects model was fitted for each of the four measurements to study the differences in those measurements between C57BL/6J control and IL-10 tm/tm mice. Each model included fixed effects of time, genotype indicator and interaction term between time and genotype, and random effects.
IL-6 levels were compared between 8-week-old IL-10 tm/tm (n ¼ 6) and C57BL/6J control mice (n ¼ 4), and between 50-week-old IL-10 tm/tm (n ¼ 14) and C57BL/6J control mice (n ¼ 25) using a cross-sectional design. All 8-week-old mice were killed by cervical dislocation, blood was collected from the heart and allowed to clot, and serum was stored at À808C. Skeletal muscle was dissected immediately from the hind limbs and placed in liquid nitrogen for gene expression experiments. Blood for IL-6 assay was obtained from tail snips in all but eight of the 50-week-old mice, and serum was stored at À808C. A subset of four older mice from each group was killed using cervical dislocation, blood was collected from the heart, and hind-limb skeletal muscle was harvested and stored in liquid nitrogen for gene expression experiments. IL-6 was quantified from stored serum samples using a Quantikine mouse solid-phase enzyme-linked immunosorbent assay (ELISA) IL-6 kit with sensitivity to 1.3 pg/mL per manufacturer's protocol (R & D Systems, Minneapolis, MN). Least squares means were calculated to test the significance of difference between groups, with multiple comparison adjusted using the Tukey method.
Differential gene expression in skeletal muscle was measured in three 50-week-old IL-10 tm/tm mice and three 50-week-old C57BL/6J mice using the National Institute of Aging (NIA) Mouse 17K Microarray (19) . Five micrograms of total RNA for each sample was radiolabeled with [
33 P]-labeled deoxycytidine triphosphate (dCTP) in a reversetranscription (RT) reaction. Membranes are hybridized with a-33 P-dCTP-labeled complementary DNA (cDNA) probes (http://www.grc.nia.nih.gov/branches/rrb/dna.htm). Microarrays were exposed to phosphorimager screens for 3 days, and scanned in a Molecular Dynamics STORM PhosphorImager (Sunnyvale, CA) at 50-lm resolution. ArrayPro software (MediaCybernetics, Silver Spring, MD) was used to convert the hybridization signals from the image into raw intensity values, and data were transferred into spreadsheets predesigned to associate the ArrayPro data format to the correct gene identities.
Normalization of raw intensity data for each experiment was achieved by calculating the average intensity for each individual data set, followed by calculation of the average of the averages for each group. This grand average was used as the basis for the computation of normalization factors that were subsequently applied to each experiment. Raw intensity data for each experiment were log 10 transformed and then used for the calculation of z scores by subtracting the average gene intensity from the raw intensity data for each gene and dividing that result by the standard deviation (SD) of all measurement intensities (20) . The significance of calculated z differences is directly inferred from measurements of the SD of the overall z difference distribution. Differential gene expression was validated in a subset of six genes chosen to represent a range of differential expression, both positive and negative, and a range of gene function. Quantitative PCR was performed using RNA extracted from hind-limb skeletal muscle from both age groups and both genotypes by the threshold cycle method normalized for the housekeeping gene glyceraldehyde-3-phosphage dehydrogenase (21) with an Mx-3000P Real Time PCR System Instrument and SYBR Green fluorescence reagents (Stratagene Inc., La Jolla, CA) using primers displayed in Table 1 .
RESULTS
Although there was no difference in appearance between the strains at age 12 months, hair loss was increasingly apparent by age 15 months in the IL-10 tm/tm mice ( Figure 1 ). Differences by mouse strain in stength, activity, and weight measures are represented graphically in Figure 2 . Although there is no significant difference in muscle strength between the IL-10 tm/tm group and control group at baseline (10 months), the linear mixed effects model demonstrated that the IL-10 tm/tm group's muscle strength declined significantly faster than that of control group, with an estimated timegenotype interaction of À0.0038 and p value , .0001 ( Table  2 ). Table 2 also shows that traveling activity was significantly different at age 14 months (estimate À22.50 with p value , .005), but the difference in the rate of decline over time was not significant (p value ¼ .079). Standing activity was not different at age 15 months between the two groups. Although the IL-10 tm/tm group had a faster decline in standing activity than the control mice, this difference was not significant ( Table 3) . Fifty-week-old IL-10 tm/tm mice (n ¼ 14) had significantly higher levels of serum IL-6 than did 50-week-old control mice (n ¼ 25) (22.31 6 18.96 vs 5.96 6 3.62 pg/lL), adjusted p value , .0001). We also found a significant difference between 8-week-old IL-10 tm/tm mice and 50-week-old IL-10 tm/tm mice (adjusted p value , .001), but no significant difference between 8-week-old and 50-week-old control mice (adjusted p value ¼ .88).
Eighty-four genes were found to be upregulated by at least 1.5-fold in the 50-week-old IL-10 tm/tm compared to the C57BL/6J matched control mice (Table 4 ). Many of the upregulated genes have some known function related to either apoptosis or mitochondria. Forty-two genes were expressed at lower levels in the IL-10 tm/tm mice compared to the C57BL/6J control strain. Most of these genes are related to transport of proteins and the regulation of cellular growth and maintenance (Table 4) . Directionality and proportionality in 4 of 6 genes tested was confirmed in the older mice (Table 5) . No age differences in expression in the skeletal muscle of these four genes were identified between 8-weekold IL10
À/À and C57BL/6J mice.
DISCUSSION
In this study, aging IL-10 tm/tm mice developed muscle weakness significantly more rapidly with increasing age than did C57/BL/6J control mice. Older, but not younger, 
IL-10
tm/tm mice had significantly higher IL-6 levels compared to age-and gender-matched C57BL/6J mice. Skeletal muscle weakness and chronic inflammation are two of the most common physical characteristics of human frailty (1-4,6 ). In addition, older IL-10 tm/tm mice showed evidence for the upregulation of several skeletal muscle genes related to apoptosis and mitochondrial function compared to control mice. Quantitative PCR confirmed some of these differences and suggested that these gene expression differences emerged only at older ages. Although preliminary, the findings of agerelated declines in strength, increases in serum IL-6 level, and altered skeletal muscle gene expression related to apoptosis and mitochondrial function provide crucial early evidence that the IL-10 tm/tm mouse may be an important animal model for both the study of human frailty and the study of the impact of chronic inflammation in aging.
The underlying biological basis for frailty is likely multisystemic and stems from age-related biological changes, genetic predisposition, and chronic disease states (12, 22) . The activation of IL-6-related inflammatory systems has consistently been shown to produce adverse health outcomes and frailty in older adults, and is therefore a major target of recent biological studies on aging (8) . NFjB is the critical gateway molecule to the production of inflammatory mediators such as IL-6 and is therefore an important target of etiologic investigations of frailty and other aging-related pathophysiological processes (8, 14) . The IL-10 tm/tm mouse develops increased inflammatory signaling because it cannot produce the antiinflammatory cytokine IL-10, which normally attenuates NF-jB signaling and dampens inflammatory activation (23) .
It is not clear why IL-6 levels increase only in older but not younger IL-10 tm/tm mice. Lipopolysaccharides (LPS) from infections, chronic disease states that stimulate inflammatory cytokines tumor necrosis factor-alpha (TNF-a) and IL-1, and age-related increases in free radicals such as H 2 O 2 stimulate NF-jB activation could trigger these increases in older animals (24) . However, given that the study mice were kept in barrier conditions and carefully monitored for infections and chronic disease states, one can speculate that age-related increases in oxidative stress may be an important age-related trigger of NF-jB-related inflammatory activation and hence frailty in these mice.
Other etiologic mechanisms may also have played an important role in the development of differential muscle weakness in these older IL-10 tm/tm mice. Apoptosis has been noted to be accelerated in some aging tissues with rapid turnover, including liver and white blood cells (25) . There is also increasing evidence that inflammation-induced apoptotic pathways, specifically those related to mitochondria, are also important in age-related muscle decline (26) . The biological relationship between loss of IL-10 and apoptosis has been characterized previously in liver, in part due to the loss of protection from apoptosis known to be induced by proinflammatory cytokines (27) . Although this potential biologic pathway to accelerated muscle decline in frail, older adults has not yet been confirmed, the findings from this preliminary gene expression study provide rationale for the further study of apoptotic changes in the skeletal muscle of frail humans (26) .
There are several factors that support the utilization of IL-10 tm/tm mice in the future study of frailty. First, the development of increased inflammation and decreased strength with age is consistent with two critical components of human frailty. Second, the IL-10 tm/tm mouse is relatively long lived and develops modest inflammatory changes only later in life, similar to frail humans. This late-life activation provides an important opportunity to study the longitudinal development of multisystem alterations related to inflammation, and how chronic inflammation may trigger multisystem changes. Third, of the 17,000 genes measured in the expression array, many of those altered were related to mitochondrial function and apoptosis, biological realms important in aging research.
There are also several factors that may limit the use of IL-10 tm/tm mice in future studies of frailty. First, these mice are genetically altered, and the loss of the IL-10 gene may contribute to biologic changes such as apoptosis induction that are different than those observed in free-living frail humans (27) . Second, because these mice must be kept in barrier conditions to prevent illness, they are also less representative of free-living frail adults (16, 17) . Third, although the mice do on average display increased serum IL-6 in older age groups, the wide variation in these levels suggests that undetected chronic illness may be present. Hence, any future use of this model for frailty research must include very careful monitoring for infection and chronic disease states. Other limitations of this study, not specific to this strain of mouse, include the lack of (i) fine motor measures, (ii) knowledge of estrous status, (iii) early life activity measures, (iv) food intake measurement, (v) detailed body mass index information, and (vi) males in the population. Finally, although the array data may provide important biological clues for frailty research, it is exploratory in nature and must be confirmed and extended before further etiologic studies are undertaken. Despite these limitations, the IL-10 tm/tm mouse develops important physical and biological characteristics of human frailty as it ages, which support its further development as a mouse model for the study of frailty.
